A PLACEBO-CONTROLLED DOUBLE-BLIND-STUDY OF EPALRESTAT (ONO-2235) IN PATIENTS WITH DIABETIC NEUROPATHY

被引：20
|
作者：
GOTO, Y [1 ]
HOTTA, N [1 ]
SHIGETA, Y [1 ]
SAKAMOTO, N [1 ]
KITO, S [1 ]
MATSUOKA, K [1 ]
TAKAHASHI, A [1 ]
KIKKAWA, R [1 ]
SAKUMA, A [1 ]
机构：
[1] NAGOYA UNIV,SCH MED,DEPT INTERNAL MED 3,65 TSURUMAI CHO,SHOWA KU,NAGOYA,AICHI 466,JAPAN
来源：
DIABETIC MEDICINE | 1993年 / 10卷 / 05期
关键词：
ALDOSE REDUCTASE INHIBITOR; CLINICAL TRIALS; DIABETIC NEUROPATHY; EPALRESTAT; HEMOGLOBIN A1C; NERVE CONDUCTION VELOCITY;
D O I：
10.1111/j.1464-5491.1993.tb00197.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：S39 / S43
页数：5
相关论文
共 50 条
  • [1] EFFECTS OF AN ALDOSE REDUCTASE INHIBITOR, EPALRESTAT, ON DIABETIC NEUROPATHY - CLINICAL BENEFIT AND INDICATION FOR THE DRUG ASSESSED FROM THE RESULTS OF A PLACEBO-CONTROLLED DOUBLE-BLIND-STUDY
    GOTO, Y
    HOTTA, N
    SHIGETA, Y
    SAKAMOTO, N
    KIKKAWA, R
    BIOMEDICINE & PHARMACOTHERAPY, 1995, 49 (06) : 269 - 277
  • [2] A double-blind placebo-controlled study of the efficacy of cerenin on diabetic neuropathy
    Thajeb, P
    Lin, MS
    Chen, PH
    NEUROLOGY, 1996, 46 (02) : 1060 - 1060
  • [3] STRUCTURAL ELUCIDATION OF EPALRESTAT(ONO-2235), A POTENT ALDOSE REDUCTASE INHIBITOR, AND ISOMERIZATION OF ITS DOUBLE-BONDS
    ISHIDA, T
    IN, Y
    INOUE, M
    UENO, Y
    TANAKA, C
    HAMANAKA, N
    TETRAHEDRON LETTERS, 1989, 30 (08) : 959 - 962
  • [4] BULIMIA TREATED WITH IMIPRAMINE - A PLACEBO-CONTROLLED, DOUBLE-BLIND-STUDY
    POPE, HG
    HUDSON, JI
    JONAS, JM
    YURGELUNTODD, D
    AMERICAN JOURNAL OF PSYCHIATRY, 1983, 140 (05): : 554 - 558
  • [5] PLACEBO-CONTROLLED, DOUBLE-BLIND-STUDY ON THE HEMORRHEOLOGIC EFFECTS OF MOLSIDOMIN
    ERNST, E
    MATRAI, A
    ZEITSCHRIFT FUR KARDIOLOGIE, 1987, 76 : 78 - 78
  • [6] Double-blind, placebo-controlled study of HGF gene therapy in diabetic neuropathy
    Kessler, John A.
    Smith, A. Gordon
    Cha, Bong-Soo
    Choi, Sung Hee
    Wymer, James
    Shaibani, Aziz
    Ajroud-Driss, Senda
    Vinik, Aaron
    ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2015, 2 (05): : 465 - 478
  • [7] A LONG-TERM EXPERIMENTAL AND CLINICAL-STUDY OF AN ALDOSE REDUCTASE INHIBITOR, ONO-2235, ON DIABETIC NEUROPATHY
    HOTTA, N
    KAKUTA, H
    KOH, N
    SAKAKIBARA, F
    NAKAMURA, J
    KITOH, R
    MATSUMAE, H
    SAKAMOTO, N
    DIABETOLOGIA, 1987, 30 (07) : A533 - A533
  • [8] A RANDOMIZED PLACEBO-CONTROLLED DOUBLE-BLIND-STUDY OF DANAZOL IN HEMOPHILIA-A
    MEHTA, J
    SINGHAL, S
    KAMATH, MV
    MEHTA, BC
    ACTA HAEMATOLOGICA, 1992, 88 (01) : 14 - 16
  • [9] PLACEBO-CONTROLLED, DOUBLE-BLIND-STUDY OF THE EFFECT OF VERAPAMIL IN INTERMITTENT CLAUDICATION
    KIMOSE, HH
    BAGGER, JP
    AAGAARD, MT
    PAULSEN, PK
    ANGIOLOGY, 1990, 41 (08) : 595 - 598
  • [10] PLACEBO-CONTROLLED, DOUBLE-BLIND-STUDY OF THE EFFECTS OF PROGLUMIDE IN THE TREATMENT OF SCHIZOPHRENIA
    WHITEFORD, HA
    STEDMAN, TJ
    WELHAM, J
    CSERNANSKY, JG
    POND, SM
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1992, 12 (05) : 337 - 340
12345